CHICAGO TRIBUNE: Exelon makes another try for energy changes that critics call bailout
Exelon is trying to orchestrate an unlikely end-of-session deal to pass far-reaching legislation to prop up what it says are financially...
CHICAGO TRIBUNE: Jeff Aronin of Marathon Pharmaceuticals on life after a $900M exit
After selling his pharmaceutical company, Ovation Pharmaceuticals, in 2009, Marathon Pharmaceuticals CEO Jeff Aronin sat down with the...
CHICAGO TRIBUNE: Matter healthtech incubator officially opens to crowd of more than 150
In early 2015, the American Medical Assocation and Matter launched MATTER, a healthcare technology incubator improving how physicians and...
CHICAGO TRIBUNE: Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016
The Chicago Tribune spoke to families and advocates seeking better treatment options for Duchenne muscular dystrophy as part of their...
